BIOMAT Database Logo BIOMAT Database Logo

Forty-eight-hour absorption pharmacokinetic profiles of two sustained-release theophylline preparations. 1984

L D Green, and C L Saccar, and C L Helsel, and M E Niehls, and S J McGeady, and H C Mansmann

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D008433 Mathematics The deductive study of shape, quantity, and dependence. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed) Mathematic
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D003692 Delayed-Action Preparations Dosage forms of a drug that act over a period of time by controlled-release processes or technology. Controlled Release Formulation,Controlled-Release Formulation,Controlled-Release Preparation,Delayed-Action Preparation,Depot Preparation,Depot Preparations,Extended Release Formulation,Extended Release Preparation,Prolonged-Action Preparation,Prolonged-Action Preparations,Sustained Release Formulation,Sustained-Release Preparation,Sustained-Release Preparations,Timed-Release Preparation,Timed-Release Preparations,Controlled-Release Formulations,Controlled-Release Preparations,Extended Release Formulations,Extended Release Preparations,Slow Release Formulation,Sustained Release Formulations,Controlled Release Formulations,Controlled Release Preparation,Controlled Release Preparations,Delayed Action Preparation,Delayed Action Preparations,Formulation, Controlled Release,Formulations, Controlled Release,Prolonged Action Preparation,Release Formulation, Controlled,Release Formulations, Controlled,Sustained Release Preparation,Timed Release Preparation,Timed Release Preparations
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000042 Absorption The physical or physiological processes by which substances, tissue, cells, etc. take up or take in other substances or energy.

Related Publications

L D Green, and C L Saccar, and C L Helsel, and M E Niehls, and S J McGeady, and H C Mansmann
Sustained-release theophylline. Pharmacokinetic and therapeutic comparison of two preparations.
May 1983, American journal of diseases of children (1960),
L D Green, and C L Saccar, and C L Helsel, and M E Niehls, and S J McGeady, and H C Mansmann
The absorption characteristics of six sustained-release theophylline preparations.
January 1992, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
L D Green, and C L Saccar, and C L Helsel, and M E Niehls, and S J McGeady, and H C Mansmann
Sustained-release theophylline preparations.
February 1990, The Journal of allergy and clinical immunology,
L D Green, and C L Saccar, and C L Helsel, and M E Niehls, and S J McGeady, and H C Mansmann
Sustained-release theophylline preparations.
May 1985, Drug and therapeutics bulletin,
L D Green, and C L Saccar, and C L Helsel, and M E Niehls, and S J McGeady, and H C Mansmann
Absorption of theophylline from two sustained release formulations.
January 1985, Biopharmaceutics & drug disposition,
L D Green, and C L Saccar, and C L Helsel, and M E Niehls, and S J McGeady, and H C Mansmann
Absorption and sustained release theophylline.
October 1983, Lancet (London, England),
L D Green, and C L Saccar, and C L Helsel, and M E Niehls, and S J McGeady, and H C Mansmann
[Pharmacokinetics of two theophylline sustained-release preparations in healthy humans].
November 1994, Arzneimittel-Forschung,
L D Green, and C L Saccar, and C L Helsel, and M E Niehls, and S J McGeady, and H C Mansmann
Absorption of sustained-release theophylline tablets.
July 1983, International journal of clinical pharmacology, therapy, and toxicology,
L D Green, and C L Saccar, and C L Helsel, and M E Niehls, and S J McGeady, and H C Mansmann
Variations in absorption of theophylline from two sustained-release products.
January 1986, Clinical therapeutics,
L D Green, and C L Saccar, and C L Helsel, and M E Niehls, and S J McGeady, and H C Mansmann
Absorption properties of two theophylline sustained-release products in smokers.
June 1984, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
Copied contents to your clipboard!